A Randomized Placebo-Controlled Trial of Armodafinil (Nuvigil) for Fatigue in Patients With Malignant Gliomas

This study is currently recruiting participants.
Verified November 2013 by Dana-Farber Cancer Institute
Sponsor:
Collaborators:
Dartmouth-Hitchcock Medical Center
University of California, San Diego
Beth Israel Deaconess Medical Center
Cephalon
Information provided by (Responsible Party):
Eudocia Quant Lee, MD, Dana-Farber/Brigham and Women's Cancer Center
ClinicalTrials.gov Identifier:
NCT00766467
First received: October 2, 2008
Last updated: November 5, 2013
Last verified: November 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2014
  Estimated Primary Completion Date: March 2014 (Final data collection date for primary outcome measure)